Free Trial

Apollomics (APLM) News Today

Apollomics logo
$16.12 +0.12 (+0.75%)
As of 12:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.

APLM Latest News

Apollomics Inc. Announces $2.0 Million Bridge Financing
Apollomics Reports First Half 2025 Financial Results
Apollomics Announces Settlement of Cayman Litigation
Apollomics Announces Settlement of Cayman Litigation
Apollomics Inc trading resumes
nasdaq resumes trading in Apollomics
Apollomics, Inc. Company Operational Continuity Update
Nasdaq halts Apollomics
Biotech fails trials for its leukemia drug
Apollomics Inc trading halted, volatility trading pause
Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
Apollomics announces approval, date for 1-for-100 reverse share split
Get Apollomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLM and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APLM Media Mentions By Week

APLM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APLM
News Sentiment

0.00

0.56

Average
Medical
News Sentiment

APLM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APLM Articles
This Week

0

2

APLM Articles
Average Week

Get the Latest News and Ratings for APLM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Apollomics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:APLM) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners